In the Finish study by Lahtinen et al. [60], a few carriers of high-penetrance cancer predisposition genes were identified, including BRCA1, BRCA2, and PALB2 (each once in adult patients with hematological malignancies). This evidence concerns the gene BRCA1 and hematologic disorder.